Tina Marriott Larson's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 14,286 Class A Common Stock done at an average price of $6.2 . Disclosure was reported to the exchange on Nov. 15, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.17 per share. | 15 Nov 2024 | 14,286 | 506,852 | - | 6.2 | 88,216 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2024 | 6,000 | 452,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 24 Oct 2024 | 6,000 | 521,138 | - | 6.3 | 37,855 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 24 Oct 2024 | 6,000 | 527,138 | - | 1.1 | 6,360 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 26 Sep 2024 | 6,000 | 527,138 | - | 1.1 | 6,360 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 26 Sep 2024 | 6,000 | 521,138 | - | 7.0 | 42,005 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 29 Aug 2024 | 6,000 | 527,138 | - | 1.1 | 6,360 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.56 per share. | 29 Aug 2024 | 6,000 | 521,138 | - | 7.6 | 45,376 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 6,000 | 464,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. | 15 Aug 2024 | 14,319 | 521,138 | - | 6.7 | 95,794 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 8.13 per share. | 25 Jul 2024 | 6,000 | 535,457 | - | 8.1 | 48,809 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 25 Jul 2024 | 6,000 | 541,457 | - | 1.1 | 6,360 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2024 | 6,000 | 470,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2024 | 6,000 | 476,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 27 Jun 2024 | 6,000 | 535,457 | - | 7.2 | 43,290 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 27 Jun 2024 | 6,000 | 541,457 | - | 1.1 | 6,360 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 30 May 2024 | 3,000 | 538,457 | - | 1.1 | 3,180 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 8.78 per share. | 30 May 2024 | 3,000 | 535,457 | - | 8.8 | 26,325 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.01 per share. | 15 May 2024 | 9,998 | 533,233 | - | 10.0 | 100,080 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2024 | 3,000 | 485,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 25 Apr 2024 | 3,000 | 543,231 | - | 7.7 | 23,021 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 25 Apr 2024 | 3,000 | 546,231 | - | 1.1 | 3,180 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 21 Mar 2024 | 8,000 | 647,982 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 8,000 | 488,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 10.70 per share. | 21 Mar 2024 | 7,390 | 640,592 | - | 10.7 | 79,065 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 11.34 per share. | 21 Mar 2024 | 610 | 639,982 | - | 11.3 | 6,915 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Marriott Larson Tina | President and COO | Sale of securities on an exchange or to another person at price $ 14.90 per share. | 22 Feb 2024 | 8,000 | 639,982 | - | 14.9 | 119,160 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Larson Marriott | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 8,000 | 496,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Marriott Larson Tina | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 22 Feb 2024 | 8,000 | 647,982 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Larson Tina Marriott | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.43 per share. | 15 Feb 2024 | 5,379 | 639,982 | - | 12.4 | 66,861 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 447,917 | 447,917 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Larson Tina Marriott | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 223,958 | 648,161 | - | 0 | Class A Common Stock | |
Recursion Pharmaceuticals ...
|
Tina Larson Marriott | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 9,655 | 424,203 | - | 0 | Class A Common Stock | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. | 09 Feb 2024 | 2,800 | 645,361 | - | 10.1 | 28,252 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2024 | 8,000 | 504,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Larson Marriott Tina | President and COO | Sale of securities on an exchange or to another person at price $ 10.35 per share. | 25 Jan 2024 | 8,000 | 414,548 | - | 10.3 | 82,762 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Larson Tina Marriott | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 25 Jan 2024 | 8,000 | 422,584 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Larson Marriott Tina | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 8,000 | 512,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Larson Tina Marriott | President and COO | Sale of securities on an exchange or to another person at price $ 10.58 per share. | 28 Dec 2023 | 8,000 | 414,548 | - | 10.6 | 84,654 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Marriott Tina Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 28 Dec 2023 | 8,000 | 422,548 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 24 Aug 2023 | 3,000 | 421,782 | - | 1.1 | 3,180 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2023 | 3,000 | 529,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 8.64 per share. | 24 Aug 2023 | 2,937 | 418,845 | - | 8.6 | 25,373 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 9.46 per share. | 24 Aug 2023 | 63 | 418,782 | - | 9.5 | 596 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share. | 15 Aug 2023 | 5,378 | 418,782 | - | 9.2 | 49,370 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2023 | 8,000 | 532,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 27 Jul 2023 | 8,000 | 432,160 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 14.05 per share. | 27 Jul 2023 | 4,373 | 424,160 | - | 14.0 | 61,424 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 27 Jul 2023 | 3,627 | 428,533 | - | 13.1 | 47,570 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 29 Jun 2023 | 3,000 | 427,160 | - | 1.1 | 3,180 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 3,000 | 540,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.49 per share. | 29 Jun 2023 | 3,000 | 424,160 | - | 7.5 | 22,470 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 3,000 | 543,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 31 May 2023 | 3,000 | 427,160 | - | 1.1 | 3,180 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 8.63 per share. | 31 May 2023 | 3,000 | 424,160 | - | 8.6 | 25,888 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 15 May 2023 | 5,415 | 422,429 | - | 5.6 | 30,324 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.82 per share. | 23 Feb 2023 | 8,000 | 427,844 | - | 7.8 | 62,540 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 23 Feb 2023 | 8,000 | 435,844 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2023 | 8,000 | 546,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 15 Feb 2023 | 1,603 | 427,844 | - | 8.4 | 13,529 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 434,122 | 434,122 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 217,061 | 422,808 | - | 0 | Class A Common Stock | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 9,732 | 432,540 | - | 0 | Class A Common Stock | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.55 per share. | 01 Feb 2023 | 3,093 | 429,447 | - | 8.5 | 26,445 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 8.07 per share. | 26 Jan 2023 | 8,000 | 203,654 | - | 8.1 | 64,547 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 26 Jan 2023 | 8,000 | 211,654 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2023 | 8,000 | 554,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2022 | 8,000 | 562,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 7.70 per share. | 29 Dec 2022 | 8,000 | 203,654 | - | 7.7 | 61,566 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 29 Dec 2022 | 8,000 | 211,654 | - | 1.1 | 8,480 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 16,000 | 570,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 10.96 per share. | 15 Nov 2022 | 16,000 | 203,654 | - | 11.0 | 175,402 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 15 Nov 2022 | 16,000 | 219,654 | - | 1.1 | 16,960 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.86 per share. | 15 Nov 2022 | 1,453 | 203,654 | - | 11.9 | 17,233 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 27 Oct 2022 | 16,000 | 221,107 | - | 1.1 | 16,960 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2022 | 16,000 | 586,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 27 Oct 2022 | 16,000 | 205,107 | - | 10.7 | 171,450 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2022 | 16,000 | 602,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 29 Sep 2022 | 16,000 | 221,107 | - | 1.1 | 16,960 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 10.86 per share. | 29 Sep 2022 | 15,936 | 205,171 | - | 10.9 | 173,011 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 11.53 per share. | 29 Sep 2022 | 64 | 205,107 | - | 11.5 | 738 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 16,000 | 618,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 12.60 per share. | 15 Aug 2022 | 16,000 | 295,107 | - | 12.6 | 201,637 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 15 Aug 2022 | 16,000 | 221,107 | - | 1.1 | 16,960 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.96 per share. | 15 Aug 2022 | 1,453 | 205,107 | - | 13.0 | 18,831 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 16 May 2022 | 1,458 | 206,560 | - | 5.7 | 8,267 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2022 | 58,500 | 634,000 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 04 Mar 2022 | 58,500 | 208,018 | - | 1.1 | 62,010 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 18 Feb 2022 | 16,000 | 149,518 | - | 1.1 | 16,960 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 16,000 | 692,500 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 4,000 | 708,500 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. | 14 Feb 2022 | 4,000 | 133,518 | - | 1.1 | 4,240 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 159,226 | 159,226 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 79,613 | 127,954 | - | 0 | Class A Common Stock | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 4,784 | 4,784 | - | - | Stock Option (Right to Buy) | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 2,392 | 130,346 | - | 0 | Class A Common Stock | |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.40 per share. | 04 Feb 2022 | 828 | 129,518 | - | 11.4 | 9,439 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 16 Dec 2021 | 1,160 | 48,840 | - | 18.1 | 20,983 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 19.17 per share. | 16 Dec 2021 | 1,040 | 47,800 | - | 19.2 | 19,933 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 19.78 per share. | 16 Dec 2021 | 300 | 47,500 | - | 19.8 | 5,933 | Class A Common Stock |
Recursion Pharmaceuticals ...
|
Tina Marriott Larson | President and COO | Sale of securities on an exchange or to another person at price $ 18.81 per share. | 18 Nov 2021 | 1,798 | 50,702 | - | 18.8 | 33,828 | Class A Common Stock |